ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Precision Neuroscience & Neuromodulation Program
The Director of Business Development leads corporate development initiatives to drive growth and strategic partnerships. This role involves identifying new business opportunities, building relationships with key stakeholders, and executing plans to expand the company's market presence. The position requires a strategic mindset to align business development efforts with overall corporate objectives.
The Precision Neuroscience & Neuromodulation (PNN) program at Massachusetts General Hospital (MGH) focuses on identifying novel biomarkers and therapeutic approaches for neurological and psychiatric conditions. The program leverages multimodal neuroimaging, electrophysiology, cognitive neuroscience, computational modeling, and noninvasive brain stimulation to investigate brain circuitry and cognitive abilities. It also hosts clinical trials spanning biomarker discovery, computational simulation, and clinical testing to develop cognitive enhancement and brain health solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precision Neuroscience & Neuromodulation Program.
6% below the average for this role